Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Groups

Publications

  • Matias-Guiu, X; Temprana-Salvador, J; Lopez, PG; Kammerer-Jacquet, SF; Rioux-Leclercq, N; Clark, D; Schürch, CM; Fend, F; Mattern, S; Snead, D; Fusco, N; Guerini-Rocco, E; Rojo, F; Brevet, M; Tellez, MS; Dei Tos, A; di Maio, T; Ramírez-Peinado, S; Sheppard, E; Bannister, H; Gkiokas, A; Arpaia, M; Ben Dhia, O; Martino, N

    Implementing digital pathology: qualitative and financial insights from eight leading European laboratories

    VIRCHOWS ARCHIV -. .

    [doi:10.1007/s00428-025-04064-y]

  • Maiques, O; Sallan, MC; Laddach, R; Pandya, P; Varela, A; Crosas-Molist, E; Barcelo, J; Courbot, O; Liu, YB; Graziani, V; Arafat, Y; Sewell, J; Rodriguez-Hernandez, I; Fanshawe, B; Jung-Garcia, Y; Imbert, PRC; Grasset, EM; Albrengues, J; Santacana, M; Macià, A; Tarragona, J; Matias-Guiu, X; Marti, RM; Tsoka, S; Gaggioli, C; Orgaz, JL; Fruhwirth, GO; Wallberg, F; Betteridge, K; Reyes-Aldasoro, CC; Haider, S; Braun, A; Karagiannis, SN; Elosegui-Artola, A; Sanz-Moreno, V

    Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis

    Nature Communications 16 -. .

    [doi:10.1038/s41467-025-56299-7]

  • Rodríguez-Martínez, A; Torrejón-Escribano, B; Eritja, N; Dorca-Arévalo, J; Gabaldón, C; Sévigny, J; Matias-Guiu, X; Martín-Satué, M

    Endometrial epithelial cell organoids as tools for studying the CD39 family of enzymes and for validating enzyme inhibitors

    HISTOLOGY AND HISTOPATHOLOGY 40 171-182. .

    [doi:10.14670/HH-18-782]

  • Quesada, S; Penault-Llorca, F; Matias-Guiu, X; Banerjee, S; Barberis, M; Coleman, RL; Colombo, N; Defazio, A; Mcneish, IA; Nogueira-Rodrigues, A; Oaknin, A; Pignata, S; Pujade-Lauraine, É; Rouleau, E; Ryska, A; van der Merwe, N; Van Gorp, T; Vergote, I; Weichert, W; Wu, XH; Ray-Coquard, I; Pujol, P

    Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics

    EUROPEAN JOURNAL OF CANCER 215 115169-115169. .

    [doi:10.1016/j.ejca.2024.115169]

  • Vredea, SW; Van Weelden, WJ; Bulten, J; Gilks, CB; Teerenstra, S; Huvila, J; Matias-Guiu, X; Gil-Moreno, A; Asbergerj, J; Sweegers, S; van der Putten, LJM; Kuesters-Vandevelde, HVN; Reijnen, C; Colasi, E; Hausnerova, J; Weinberger, V; Snijders, MPLM; Vinklerova, P; Ravaggi, A; Odicino, F; Bignotti, E; Mcalpine, JN; Kruitwagen, R; Pijnenborga, JMA

    Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer

    GYNECOLOGIC ONCOLOGY 192 15-23. .

    [doi:10.1016/j.ygyno.2024.10.028]

  • Matias-Guiu, X; Raspollini, MR; Kulka, J; Ryska, A; Dieri, RA; Schirmacher, P; European Society of Pathology ESP

    The role of the pathologist in the design and conducting of biomarker-driven clinical trials in cancer: position paper of the European Society of Pathology

    VIRCHOWS ARCHIV -. .

    [doi:10.1007/s00428-024-04005-1]

  • Moreno-Moreno, E; Caniego-Casas, T; Carretero-Barrio, I; Cortés, A; Muriel, A; Domínguez-Rullán, JA; Martín-Gromaz, C; Moreno-Bueno, G; Matías-Guiu, X; Palacios, J; Pérez-Mies, B

    Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 48 1580-1587. .

    [doi:10.1097/PAS.0000000000002308]

  • Matias-Guiu, X; Lax, S; Raspollini, MR; Palacios, J; Zheng, WX; Liu, CR; de Brot, L; Lordello, L; Hardisson, D; Gaffney, D; Mutch, D; Scambia, G; Creutzberg, CL; Fotopoulou, C; Berek, JS; Concin, N

    FIGO 2023 staging for endometrial cancer, when, if it is not now?

    EUROPEAN JOURNAL OF CANCER 213 115115-115115. .

    [doi:10.1016/j.ejca.2024.115115]

  • Morice, P; Scambia, G; Abu-Rustum, NR; Acien, M; Arena, A; Brucker, S; Cheong, Y; Collinet, P; Fanfani, F; Filippi, F; Eriksson, AGZ; Gouy, S; Harter, P; Matias-Guiu, X; Pados, G; Pakiz, M; Querleu, D; Rodolakis, A; Rousset-Jablonski, C; Stepanyan, A; Testa, AC; Macklon, KT; Tsolakidis, D; De Vos, M; Planchamp, F; Grynberg, M

    Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE

    LANCET ONCOLOGY 25 602-610. .

    [doi:10.1016/S1470-2045(24)00262-6]

  • Navarro-Masip, E; Petit, NM; Salinas-Roca, B; Herrerías, F; VILARDELL, F; de la Fuente, MC; Pallares, J; Santamaría, M; Zorzano-Martínez, M; Sánchez, E; Matías-Guiu, X; López-Cano, C; Soler, AG; León-Mengíbar, J; Bueno, M; Lecube, A

    Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver®) Diagnoses

    Obesity Facts 17 473-482. .

    [doi:10.1159/000538765]

  • von der Heyde, S; Raman, N; Gabelia, N; Matias-Guiu, X; Yoshino, T; Tsukada, Y; Melino, G; Marshall, JL; Wellstein, A; Juhl, H; Landgrebe, J

    Tumor specimen cold ischemia time impacts molecular cancer drug target discovery

    CELL DEATH & DISEASE 15 691-691. .

    [doi:10.1038/s41419-024-07090-x]

  • Casas-Arozamena, C; Vilar, A; Cueva, J; Arias, E; Sampayo, V; Diaz, E; Oltra, SS; Moiola, CP; Cabrera, S; Cortegoso, A; Curiel, T; Abalo, A; Serrano, MP; Domingo, S; Padilla-Iserte, P; de la Cruz, MA; Hernández, A; García-Pineda, V; Ruiz-Bañobre, J; López, R; Matias-Guiu, X; Colás, E; Gil-Moreno, A; Abal, M; Moreno-Bueno, G; Muinelo-Romay, L

    Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application

    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 43 264-264. .

    [doi:10.1186/s13046-024-03158-w]

Projects

  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
  • INTENSIFICACION 2012
  • INTENSIFICACION 2011
  • Alteraciones moleculares relacionados con la progresión tumoral en el cáncer de endometrio
  • AYUDAS PREDOCTORALES DE FORMACION EN INVESTIGACION
  • Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
  • ESTUDIO DE VIABILIDAD DEL ESTADIAJE MEDIANTE EL SISTEMA SYSMEX RD-100i,DE ACIDOS NUCLEICOS, PARA LA DETECCION DE METASTASIS EN NODULOS LINFATICOS EN EL CANCER COLORRECTAL
  • Caracterización de las células neoplásicas inmaduras pluripotenciales (células madre neoplásicas) en el cáncer de endometrio. Implicaciones Patogénicas, pronósticas y terapeuticas
  • CARCINOMA DE ENDOMETRIO. VALORACION DELECCIONES Y AMPLIFICACIONES DE REGIONES CROMOSOMICAS MEDIANTE ARRAYS DE CGH
  • SOLICITUD PARA EL SUBPROGRAMA ACTEPARQ INCLUIDO EN EL PLAN NACIONAL DE I+D+I 2008-2011 PARA PROYECTOS DE IMPLANTACION O MEJORA DE INFRAEST.EN ACTUACIONES CIENTIFICAS Y TECNOLOGICAS
  • EVALUACION DE LA EFICACIA DE LA INMUNOHISTOQUIMICA Y LA PATOLOGIA MOLECULAR EN LA IDENTIFICACION DEL ORIGEN PRIMARIO DEL TUMOR EN PACIENTES QUE SE PRESENTAN CON CANCERES METASTATIC
  • SOMNOLENCIA DIURNA, ACTIVIDAD SIMPATICA E HTA EN PACIENTES CON SINDROME DE APNEA HIPOAPNEA DEL SUEÑO